Strength Training on a GLP-1: Why It's Non-Negotiable

If there's one piece of advice about GLP-1 medications that clinicians are increasingly blunt about, it's this: strength training isn't optional. Cardio helps your heart. It does not prevent muscle loss. Only resistance training does that — and the evidence behind why is worth understanding in full.

The scale of the problem strength training solves

Across clinical trials, roughly 30–40% of the weight lost on GLP-1 medications comes from lean body mass, not fat — a finding consistent across the STEP and SURMOUNT trial data (Gastroenterology Advisor, 2026). Some sources put the figure as high as 40%, specifically noting the consequences: reduced metabolism, reduced strength, and worse blood sugar control (Ubie Health, 2026). Without a specific countermeasure, this isn't a minor side detail of treatment — it's a substantial share of the actual outcome.

Why cardio doesn't solve this problem

This distinction is worth stating plainly, because it's commonly misunderstood: cardio is excellent for heart health, but it does not prevent muscle loss effectively during weight loss (Ubie Health, 2026). Resistance training sends your body a specific, direct physiological signal — in the words of one clinical resource, it tells your body "keep this muscle, I need it" (Ubie Health, 2026). Cardiovascular exercise simply doesn't send that same signal. A Mayo Clinic resource on this topic is equally direct: aerobic activity is important for cardiovascular health, but it is less effective than resistance training for preserving muscle specifically (Mayo Clinic, 2026) — the ideal approach includes both, but they are not interchangeable for this particular purpose.

Why muscle loss matters beyond appearance

Metabolic rate. Muscle tissue consumes more energy at rest than fat tissue — more muscle means a higher resting metabolic rate, which makes long-term weight maintenance genuinely easier, not just aesthetically different (Ubie Health, 2026).

Physical function. Strength and mobility enable daily activities, reduce injury risk, and support bone health (Ubie Health, 2026) — this matters at every age, but becomes particularly important as people get older.

Blood sugar control. Muscle is a primary site for glucose disposal in the body. Preserving muscle mass helps maintain insulin sensitivity, directly complementing — not competing with — the blood sugar benefits your GLP-1 medication is already providing (Ubie Health, 2026).

Long-term risk. Without exercise, patients on GLP-1 therapy are at meaningfully greater risk of sarcopenia (age- or illness-related muscle loss) and functional decline (Gastroenterology Advisor, 2026).

What the actual training guidelines recommend

Clinical recommendations are fairly consistent across sources. A practical, evidence-based target is at least 150 minutes of moderate-intensity aerobic exercise per week, combined with resistance training at least twice per week (Gastroenterology Advisor, 2026; Cleveland Clinic, 2026). Some sources recommend a slightly higher resistance training frequency specifically — 2 to 4 sessions per week targeting all major muscle groups (Ubie Health, 2026).

A few specific elements matter for making this effective, not just present:

• Progressive overload. Training should involve progressively more challenging weights over time, not the same routine indefinitely (Ubie Health, 2026).

• Adequate protein alongside training. Resistance training without sufficient protein intake — generally 1.2 to 1.6 grams per kilogram of body weight daily — significantly limits how effective the training itself can be (Ubie Health, 2026; David Protein, 2026).

• Recovery. Sleep, hydration, and planned rest days are explicitly part of an effective programme, not an afterthought (Ubie Health, 2026).

• A gradual start if you're new to training. Beginning with low-impact movement, such as walking or light strength exercises, allows your body to adapt as weight and energy intake change, with intensity and volume increasing over time as strength and confidence build (David Protein, 2026).

• 
  

Why this is being studied so directly right now

This isn't just accumulated clinical opinion — it's an active area of formal research. A registered study protocol is currently examining, using an interrupted time-series design, the effects of resistance training specifically during GLP-1 receptor agonist treatment, comparing people who began GLP-1 treatment alongside resistance training against a control group doing resistance training alone (Registered Report, medRxiv, 2025). The fact that dedicated research infrastructure is being built specifically around this question underscores how seriously the clinical and research community is now taking the muscle preservation issue.

A specific point for women, particularly post-menopause

One clinical point worth highlighting specifically: as people get older, and especially for women in post-menopause, building muscle is one of the only ways to meaningfully increase basal metabolic rate (Cleveland Clinic, 2026). Combined with the fact that once muscle mass is lost, it becomes considerably harder to regain (Cleveland Clinic, 2026), this makes resistance training during active GLP-1 treatment a particularly high-stakes decision for this group specifically — not just a general recommendation.

Why "non-negotiable" is the right word, not an exaggeration

Given the consistent 30–40% figure for lean mass loss across major trials, and given that only resistance training — not cardio, not diet alone — has been shown to directly counteract it, framing strength training as optional understates what's actually at stake in your treatment outcome. It's not a nice-to-have alongside your medication; it's the specific intervention that determines whether your weight loss is mostly fat or a meaningful share of muscle.

This is exactly why our While You're On It programme treats resistance training as a core pillar, not an optional add-on — structured training guidance built around the frequency, progression, and recovery principles the evidence actually supports.

Because effective resistance training depends on adequate protein intake to work, our Alongside Daily Support powder can help you consistently hit the protein targets your training needs to pay off.

Muscle preservation matters just as much through the transition off treatment — our Coming Off It programme carries the same training principles into the maintenance phase.

And if you're new to resistance training or want a programme built specifically around your current fitness level, our 1:1 coaching can help you start safely and progress properly.

The bottom line

Up to 30–40% of the weight lost on a GLP-1 medication can come from muscle, not fat — and cardio alone does not prevent this; only resistance training does. Clinical guidelines consistently point to at least twice-weekly resistance training, combined with adequate protein intake and proper recovery, as the specific intervention that changes this outcome. Given what's genuinely at stake for your metabolism, physical function, and blood sugar control, treating strength training as optional undersells exactly how much it determines the quality, not just the quantity, of your results.

This article is for general information and isn't a substitute for personalised medical or exercise advice. Speak to your prescriber before starting a new exercise programme, particularly if you have existing health conditions.

References

Cleveland Clinic. (2026, May 5). Here's why you should exercise while taking GLP-1s. https://health.clevelandclinic.org/exercise-for-glp-1-use

David Protein. (2026, June 15). Protein on GLP-1s: How to preserve muscle while losing weight. https://davidprotein.com/blogs/the-column/protein-glp1-medications-muscle-preservation

Gastroenterology Advisor. (2026, February 4). Weight training and GLP-1 therapy for weight management. https://www.gastroenterologyadvisor.com/features/weight-training-and-glp-1-therapy-for-optimal-weight-management/

Mayo Clinic. (2026, May 29). GLP-1 medications and muscle loss: What to know about nutrition and supplements. https://store.mayoclinic.com/education/glp-1-medications-and-muscle-loss-what-to-know-about-nutrition-and-supplements/

Registered Report. (2025). Preserving musculoskeletal health through resistance training in individuals undergoing glucagon-like peptide-1 receptor agonist therapy: A controlled interrupted time-series analysis. medRxiv. https://www.medrxiv.org/content/10.1101/2025.06.24.25330195.full.pdf

Ubie Health. (2026, July 2). Muscle preservation: Why resistance training is essential during GLP-1 weight loss [Doctor's Note]. https://ubiehealth.com/doctors-note/glp-1-resist-train-lean-muscle-mass-preservation4771q1